Identification of acetylcholinesterase inhibitors using homogenous cell‐based assays in quantitative high‐throughput screening platforms
Shuaizhang Li(National Institutes of Health), Menghang Xia(National Center for Advancing Translational Sciences), Ruili Huang(National Institutes of Health), Yitong Liu(Jinan University), Bin Zhao(Northwestern Polytechnical University), Samuel G. Solomon(National Institutes of Health), Michael F. Santillo(Center for Food Safety and Applied Nutrition)
Cited by 15
Related Papers
Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor
|Toxicological Sciences|2011|753
<i>In Vitro</i> Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens
|Environmental Health Perspectives|2008|349
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
|Toxicological Sciences|2010|314
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
|Cell Discovery|2018|194
Toxicity and transformation of graphene oxide and reduced graphene oxide in bacteria biofilm
|The Science of The Total Environment|2016|133